BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9685375)

  • 1. Mapping of a molecular determinant for protein kinase C betaII isozyme function.
    Gökmen-Polar Y; Fields AP
    J Biol Chem; 1998 Aug; 273(32):20261-6. PubMed ID: 9685375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylglycerol is a physiologic activator of nuclear protein kinase C.
    Murray NR; Fields AP
    J Biol Chem; 1998 May; 273(19):11514-20. PubMed ID: 9565565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C chimeras: catalytic domains of alpha and beta II protein kinase C contain determinants for isotype-specific function.
    Walker SD; Murray NR; Burns DJ; Fields AP
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9156-60. PubMed ID: 7568092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.
    Maines MD; Miralem T; Lerner-Marmarosh N; Shen J; Gibbs PE
    J Biol Chem; 2007 Mar; 282(11):8110-22. PubMed ID: 17227757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of a beta II protein kinase C-selective nuclear membrane activation factor in human leukemia cells.
    Murray NR; Burns DJ; Fields AP
    J Biol Chem; 1994 Aug; 269(33):21385-90. PubMed ID: 8063766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inhibition of sequestration of protein kinase C alpha/betaII by ceramide. Roles of ceramide-activated protein phosphatases and phosphorylation/dephosphorylation of protein kinase C alpha/betaII on threonine 638/641.
    Kitatani K; Idkowiak-Baldys J; Hannun YA
    J Biol Chem; 2007 Jul; 282(28):20647-56. PubMed ID: 17504762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. betaII protein kinase C is required for the G2/M phase transition of cell cycle.
    Thompson LJ; Fields AP
    J Biol Chem; 1996 Jun; 271(25):15045-53. PubMed ID: 8663071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective translocation of beta II-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells.
    Hocevar BA; Fields AP
    J Biol Chem; 1991 Jan; 266(1):28-33. PubMed ID: 1845965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of elements of protein kinase C-alpha regulatory domain to lamin B1.
    Tabellini G; Bortul R; Aluigi M; Billi AM; Bareggi R; Grill V; Narducci P; Martelli AM
    Cell Signal; 2002 Oct; 14(10):819-27. PubMed ID: 12135703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis in solution of protein kinase C betaII V5-1 peptide.
    Shin C; Ahn JH; Lim Y
    Biochem Biophys Res Commun; 2005 Nov; 337(1):154-9. PubMed ID: 16182252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C beta II specifically binds to and is activated by F-actin.
    Blobe GC; Stribling DS; Fabbro D; Stabel S; Hannun YA
    J Biol Chem; 1996 Jun; 271(26):15823-30. PubMed ID: 8663149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of protein kinase C (PKC) phosphorylation sites on human lamin B. Potential role of PKC in nuclear lamina structural dynamics.
    Hocevar BA; Burns DJ; Fields AP
    J Biol Chem; 1993 Apr; 268(10):7545-52. PubMed ID: 8463284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of nuclear beta II protein kinase C as a mitotic lamin kinase.
    Goss VL; Hocevar BA; Thompson LJ; Stratton CA; Burns DJ; Fields AP
    J Biol Chem; 1994 Jul; 269(29):19074-80. PubMed ID: 8034666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of protein kinase C-alpha binding to lamin A.
    Martelli AM; Bortul R; Tabellini G; Faenza I; Cappellini A; Bareggi R; Manzoli L; Cocco L
    J Cell Biochem; 2002; 86(2):320-30. PubMed ID: 12112001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The V5 domain of protein kinase C plays a critical role in determining the isoform-specific localization, translocation, and biological function of protein kinase C-delta and -epsilon.
    Wang QJ; Lu G; Schlapkohl WA; Goerke A; Larsson C; Mischak H; Blumberg PM; Mushinski JF
    Mol Cancer Res; 2004 Feb; 2(2):129-40. PubMed ID: 14985469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of PKC betaII in anti-proliferating action of a new antitumor compound gnidimacrin.
    Yoshida M; Heike Y; Ohno S; Ikekawa T; Wakasugi H
    Int J Cancer; 2003 Jul; 105(5):601-6. PubMed ID: 12740906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C isotypes in human erythroleukemia cell proliferation and differentiation.
    Hocevar BA; Morrow DM; Tykocinski ML; Fields AP
    J Cell Sci; 1992 Mar; 101 ( Pt 3)():671-9. PubMed ID: 1522149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane binding kinetics of protein kinase C betaII mediated by the C2 domain.
    Nalefski EA; Newton AC
    Biochemistry; 2001 Nov; 40(44):13216-29. PubMed ID: 11683630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chaperones Hsp90 and Cdc37 mediate the maturation and stabilization of protein kinase C through a conserved PXXP motif in the C-terminal tail.
    Gould CM; Kannan N; Taylor SS; Newton AC
    J Biol Chem; 2009 Feb; 284(8):4921-35. PubMed ID: 19091746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding specificity for RACK1 resides in the V5 region of beta II protein kinase C.
    Stebbins EG; Mochly-Rosen D
    J Biol Chem; 2001 Aug; 276(32):29644-50. PubMed ID: 11387319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.